Literature DB >> 7827926

Familial adenomatous polyposis.

W J Campbell1, R A Spence, T G Parks.   

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant condition resulting in the development of more than 100 adenomatous polyps in the large bowel. In addition, a number of extracolonic manifestations of the condition may occur. Recently, increasing knowledge relating to the extracolonic abnormalities, and localization and sequencing of the gene for FAP, have had important implications for screening and long-term follow-up of those affected. In this review the natural history of the disease and the extracolonic manifestations associated with it are considered. Surgical management and advances in understanding at a molecular level are discussed, as well as the problems relating to screening for FAP and the implications of the new knowledge.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827926     DOI: 10.1002/bjs.1800811207

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

Review 1.  Familial adenomatous polyposis: a case report and review of the literature.

Authors:  D Beech; A Pontius; N Muni; W P Long
Journal:  J Natl Med Assoc       Date:  2001-06       Impact factor: 1.798

2.  Lung adenocarcinoma associated with familial adenomatous polyposis. Clear cell carcinoma with beta-catenin accumulation accompanied by atypical adenomatous hyperplasia.

Authors:  Akiteru Goto; Jun Nakajima; Kei Hara; Toshiro Niki; Masashi Fukayama
Journal:  Virchows Arch       Date:  2004-11-16       Impact factor: 4.064

3.  Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.

Authors:  Yoshihiko Miyamoto; Naoki Muguruma; Tetsuo Kimura; Koichi Okamoto; Masahiro Sogabe; Hiroshi Miyamoto; Seiya Kohno; Masahiko Nakasono; Hiroshige Hayashi; Yoshimi Bando; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-05-12

4.  Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli.

Authors:  J F Gebert; C Dupon; M Kadmon; M Hahn; C Herfarth; M von Knebel Doeberitz; H K Schackert
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

5.  Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis.

Authors:  I Nakada; H Ubukata; Y Goto; Y Watanabe; S Sato; T Tabuchi; T Soma
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

6.  [Regional growth preferences in hereditary, synchronous, and metachronous colorectal carcinomas. Basics of tumor surgery Part II].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

7.  Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status.

Authors:  K Heinimann; B Müllhaupt; W Weber; M Attenhofer; R J Scott; M Fried; S Martinoli; H Müller; Z Dobbie
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Authors:  Rosario Touriño; Rogelio Conde-Freire; José M Cabezas-Agrícola; Teresa Rodríguez-Aves; Maria Jesús López-Valladares; José L Otero-Cepeda; Carmen Capeans
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

Review 9.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

10.  The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register.

Authors:  S Bülow; T Faurschou Nielsen; C Bülow; M L Bisgaard; L Karlsen; F Moesgaard
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.